改良格拉斯哥昏迷评分联合血清因素预测创伤性脑损伤预后
研究纳入2011年5月至2016年7月间219例因创伤性脑损伤行去骨瓣减压术的患者,评估入院时血清因素与预后的关系,并构建结合血清因素与格拉斯哥昏迷评分的改良评分。血红蛋白、血小板、凝血酶原时间和乳酸脱氢酶与院内死亡相关,改良评分可能有助于预测院内死亡。
要点
- 入院血红蛋白、血小板、凝血酶原时间、乳酸脱氢酶与院内死亡相关。
- 因素评分由血红蛋白<13.0 g/dL、血小板<150×10³/mm³、凝血酶原时间≥13.2秒、乳酸脱氢酶≥271 U/L各计1分组成。
- 改良GCS评分=GCS评分(范围6-15)减去因素评分(范围0-4),可能有助于预测院内死亡。
核心结论
- 使用血清因素的改良GCS评分扩展了患者预后信息,与更复杂方法相当。
- 改良GCS评分可能有助于预测创伤性脑损伤患者的院内死亡。
研究设计与样本
- 回顾性研究,纳入2011年5月至2016年7月间219例因创伤性脑损伤行去骨瓣减压术的患者。
- 评估入院实验室数据,研究其与GCS和格拉斯哥结局量表的相关性。
- 改良GCS由多变量逻辑回归模型开发,并用后向逐步法验证。
主要发现
- 219例患者中男性175例(79.9%),女性44例(20.1%),平均年龄49.1±11.5岁。
- 入院血红蛋白、血小板、凝血酶原时间和乳酸脱氢酶与院内死亡相关。
- 因素评分计分方法:血红蛋白≥13.0 g/dL=0分,<13.0 g/dL=1分;血小板≥150×10³/mm³=0分,<150×10³/mm³=1分;凝血酶原时间<13.2秒=0分,≥13.2秒=1分;乳酸脱氢酶<271 U/L=0分,≥271 U/L=1分。
- 改良GCS评分=GCS评分(范围6-15)减去因素评分(范围0-4)。
关键数值与推荐
- 因素评分四项指标及阈值:血红蛋白13.0 g/dL、血小板150×10³/mm³、凝血酶原时间13.2秒、乳酸脱氢酶271 U/L。
- 改良GCS评分范围为2-15(GCS 6-15减去因素评分0-4)。
临床怎么用
- 原文结论认为改良GCS评分可能有助于预测创伤性脑损伤患者的院内死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Traumatic brain injury (TBI) is a major cause of death and disability. This study evaluated a possible relationship between serum factors at admission and the outcome of TBI. We propose a statistically validated scale for patients with TBI that combines serum factors and the Glasgow Coma Scale (GCS). METHODS: Between May 2011 and July 2016, 219 patients underwent decompressive craniectomy for TBI. We assessed laboratory data on admission, and correlations with GSC and Glasgow Outcome Scale were investigated. The modified GCS was developed from a multivariable logistic regression model, which was validated with the backward stepwise method. RESULTS: Of 219 patients with TBI enrolled in our study, 175 were men (79.9%) and 44 were women (20.1%) with a mean age of 49.1 ± 11.5 years. Initial serum values of hemoglobin, platelets, prothrombin time, and lactate dehydrogenase were associated with in-hospital mortality. The factor score was derived by adding the following points: hemoglobin (≥13.0 g/dL = 0, <13.0 g/dL = 1), platelets (≥150 × 103/mm3 = 0, <150 × 103/mm3 = 1), prothrombin time (<13.2 seconds = 0, ≥13.2 seconds = 1), and lactate dehydrogenase (<271 U/L = 0, ≥271 U/L = 1). The modified GCS score (GCS score [range, 6-15] - FS [range, 0-4]) was calculated. CONCLUSIONS: The modified GCS score using serum factors extended the information provided about patient outcomes to be comparable to more complex methods. The modified GCS score may be useful to predict in-hospital mortality in patients with TBI.
引用
- Bae IS, Chun HJ, Yi HJ, et al. Modified Glasgow Coma Scale Using Serum Factors as a Prognostic Model in Traumatic Brain Injury. World Neurosurg. 2019. PMID: 30876987. doi:10.1016/j.wneu.2019.02.197
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。